DOCU
The billings headline is shiny. The growth story? Less so.
DocuSign had a quarter that would look great on a slide deck: quarterly billings crossed $1 billion for the first time, revenue came in at $837 million, and non-GAAP EPS of $1.01 beat the Street’s $0.95 estimate. Free cash flow topped $1 billion for the year, and management did the classic “we’ve got cash, so let’s buy back more stock” move by boosting the authorization to $2.6 billion.
That’s all nice. But if you’re an investor, you know the trick: cash flow is great, unless it’s coming from a business that’s already tapped most of its runway. And that’s the problem here. DocuSign isn’t acting like a hyper-growth SaaS rocket anymore. It’s acting like a mature software utility that’s squeezing every drop out of a category it basically invented.
The market heard “8% growth” and yawned
The real tell was the guidance. For fiscal 2027, DocuSign guided for revenue of $3.484 billion to $3.496 billion — roughly 8% growth at the midpoint. For a company that still gets valued like a tech name, that’s the kind of number that makes growth investors quietly close the tab.
The core e-signature business is saturated, and even the company’s own DNR improvement to 102% says customers are spending only a little more than they were a year ago. That’s not a land-and-expand binge. That’s a polite nod at the checkout counter.
IAM: new acronym, same uphill climb
So DocuSign is trying to reinvent itself with Intelligent Agreement Management, or IAM, its AI-powered contract lifecycle platform. The pitch is that DocuSign won’t just help you sign stuff anymore — it’ll help you manage agreements from creation to renewal, like a digital ops brain for legal and procurement teams.
The company is also leaning on partnerships with Harvey and ID.me to make that story sound less like “new feature” and more like “enterprise infrastructure.” But here’s the catch: selling AI workflow software into big companies means cleaning up ancient, messy contract data first. And that’s the part nobody puts on a splashy keynote slide.
- lots of disconnected PDFs
- years of stale repositories
- painful data cleanup before any AI magic happens
That’s a hard sell, especially when Adobe and Microsoft are lurking with bundled alternatives that can look pretty good for “effectively zero incremental cost.”
Big picture: great cash cow, awkward growth phase
DocuSign’s quarter says the business is healthy. The market’s reaction says it’s no longer being priced like a growth machine. If IAM works, this could be the start of a second act. If not, DocuSign may keep doing the corporate equivalent of milking a very expensive cow. And for investors, that’s a very different movie.